Evidence map›Paper›PMID 41543638›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2026

Genotypic and phenotypic characterization of Pseudomonas aeruginosa PAV112: a virulent clinical strain causing severe pneumonia and lethal sepsis in a murine infection model.

Raissa Guará Assunção, Beatriz Gomes Vila Nova, Lully Gabrielly Silva Alves, Leticia Cely Tavares da Silva, Gabrielle Chaves Sá, Lucas Dos Santos Silva, Marcos Andrade-Silva, Amanda Vitória Sevidanes de Santana, Ivana Fiquene Zafred, Sarah Rackel Silva Soares and 7 more

Abstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Raissa Guará Assunção *Programa de Pós-Graduação em Ciências da Saúde, Universidade Federal do Maranhão, São Luís, Brazil.
Beatriz Gomes Vila Nova *Laboratório de Patogenicidade Microbiana, Universidade Ceuma, São Luís, Brazil.
Lully Gabrielly Silva AlvesLaboratório de Patogenicidade Microbiana, Universidade Ceuma, São Luís, Brazil.
Leticia Cely Tavares da SilvaLaboratório de Patogenicidade Microbiana, Universidade Ceuma, São Luís, Brazil.
Gabrielle Chaves SáLaboratório de Patogenicidade Microbiana, Universidade Ceuma, São Luís, Brazil.
Lucas Dos Santos SilvaLaboratório de Patogenicidade Microbiana, Universidade Ceuma, São Luís, Brazil.
Marcos Andrade-SilvaLaboratório de Patogenicidade Microbiana, Universidade Ceuma, São Luís, Brazil.
Amanda Vitória Sevidanes de SantanaLaboratório de Patogenicidade Microbiana, Universidade Ceuma, São Luís, Brazil.
Ivana Fiquene ZafredLaboratório de Patogenicidade Microbiana, Universidade Ceuma, São Luís, Brazil.
Sarah Rackel Silva SoaresLaboratório de Patogenicidade Microbiana, Universidade Ceuma, São Luís, Brazil.
Francisco Jonathas Rodrigues NogueiraPrograma de Pós-Graduação em Ciências da Saúde, Universidade Federal do Maranhão, São Luís, Brazil.
Maria Rosa Quaresma BomfimLaboratório de Biologia Molecular de Microrganismos, Universidade Ceuma, São Luís, Brazil.
Johnny Ramos do NascimentoPrograma de Pós-Graduação em Ciências da Saúde, Universidade Federal do Maranhão, São Luís, Brazil.
Rafael Cardoso CarvalhoPrograma de Pós-Graduação em Ciências da Saúde, Universidade Federal do Maranhão, São Luís, Brazil.
Joicy Cortez de Sá SousaDepartamento de Morfologia, Universidade Federal do Maranhão, São Luís, Brazil.
Marliete Carvalho da CostaLaboratório de Biologia Molecular de Microrganismos, Universidade Ceuma, São Luís, Brazil.
Afonso Gomes AbreuPrograma de Pós-Graduação em Ciências da Saúde, Universidade Federal do Maranhão, São Luís, Brazil. afonso.abreu@ufma.br.ORCID http://orcid.org/0000-0003-1665-0879

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 307035/2022-0 and 312349/2020-3Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão Universal 06598/22, BEPP 01822/21, ACT-01784/21 (PDGP CAPES/FAPEMA)
6 · The paper itself

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen frequently associated with hospital-acquired infections, particularly in intensive care units. This study aimed to evaluate the virulence of the clinical strain P. aeruginosa VAP112, isolated from a patient with ventilator-associated pneumonia (VAP), using a murine model of pulmonary infection. Antimicrobial susceptibility testing was performed using the VITEK® 2 system and disk diffusion method. Experiments were conducted to evaluate biofilm formation by VAP112, as well as the survival of Tenebrio molitor larvae and C57BL/6 mice. Animals were instilled with VAP112 via tracheal to evaluate the bacterial load in the organs, inflammatory markers, cell quantification, and histology of organs. Polymerase chain reaction (PCR) identified the presence of virulence and resistance genes, including exoU, exoT, exoS, phzI, phzM, oprI, blaOXA− 23, and blaOXA− 51. The strain demonstrated the ability to form biofilms and caused mortality in T. molitor larvae. In mice, tracheal instillation of VAP112 led to pneumonia with rapid progression to lethal sepsis within 48 h. This was associated with bacterial dissemination to various organs, significant increase in nitric oxide and IL-6 levels, and elevated cell counts in bone marrow and bronchoalveolar fluid. Histological analysis revealed inflammatory infiltrates, edema, and congestion in the affected organs. Taken together, these findings showed the virulence potential of P. aeruginosa VAP112 to induce severe pneumonia in animals with rapid progression to lethal sepsis. Given its great importance in the clinical context, this study underscores the urgent need for the development of novel therapeutic strategies to combat infections caused by virulent strains of P. aeruginosa.

Indexed as

Pneumonia, Ventilator-AssociatedPseudomonas aeruginosaPseudomonas InfectionsSepsisAnimalsAnti-Bacterial AgentsBiofilmsDisease Models, AnimalGenotypeHumansMaleMiceMice, Inbred C57BLMicrobial Sensitivity TestsPhenotypeVirulenceAnti-Bacterial AgentsVirulence FactorsInflammationPneumoniaPseudomonas aeruginosaSepsisVentilator-associated pneumonia

Identifiers

PMID41543638
PMCPMC12811205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.